Targeting the SARS-CoV-2 reservoir in long COVID
Amy D. Proal(Poly Med (United States)), Michael J. Peluso(University of California, San Francisco), Akiko Iwasaki(Howard Hughes Medical Institute), Stephen M. Hewitt(National Institutes of Health), David Putrino(Mount Sinai Hospital), Mark M. Painter(University of Michigan), Etheresia Pretorius(Stellenbosch University), Lael M. Yonker(Harvard University), Daniel S. Chertow(National Institutes of Health), Johan Van Weyenbergh(Rega Institute for Medical Research), Michael B. VanElzakker(Massachusetts General Hospital), Morgane Bomsel(Centre National de la Recherche Scientifique), Gene S. Tan(J. Craig Venter Institute), Diane E. Griffin(Johns Hopkins University), Yu Qian(J. Craig Venter Institute), Michela Locci(University of Pennsylvania), Soo Aleman(Karolinska University Hospital), Alessio Fasano(Harvard University), Christopher L. Dupont(J. Craig Venter Institute), Saurabh Mehandru(Icahn School of Medicine at Mount Sinai), Sara Cherry(University of Pennsylvania), Dominique Salmon(Assistance Publique – Hôpitaux de Paris), Marcus Buggert(Karolinska Institutet), E. John Wherry(University of Pennsylvania), Marcelo Freire(J. Craig Venter Institute), Steven G. Deeks(University of California, San Francisco), Michaela Müller‐Trutwin(Institut Pasteur), E. Wesley Ely(Vanderbilt University Medical Center), Vincent C. Marconi(Emory University), Linda N. Geng, Petter Brodin(Karolinska University Hospital), Nadia R. Roan(Gladstone Institutes), Helen Davies(University Hospital of Wales), Harlan M. Krumholz(Robert Wood Johnson Foundation), David A. Price(University of Colorado Denver), Timothy J. Henrich(University of California, San Francisco)
Cited by 50
Related Papers
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k